NIH-funded research R01 grant

Understanding genes beyond APOL1 that affect kidney transplants

Official title: Non-APOL1 genetic factors and kidney transplant outcomes

Funded at Columbia University Health Sciences · NIH-11138741 · Data updated 2026-11-12

This research looks at additional genetic differences, besides the APOL1 gene, that might affect how well kidney transplants work, especially for people of African ancestry.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 15, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$723,798
NIH project number5R01DK136765-03
Project IDNIH-11138741 on NIH RePORTER

Who could benefit from this research

Could help

This research uses existing genetic data from kidney transplant donor-recipient pairs, especially those of African ancestry, who were part of the APOLLO cohort.

Less likely to help

Patients who have not undergone a kidney transplant or are not of African ancestry may not directly benefit from the specific findings of this genetic analysis.

What this research studies

We are expanding an existing project called APOLLO, which already collected information from 2,800 kidney transplant donor-recipient pairs. Our goal is to look at a wider range of genetic information, beyond just the APOL1 gene, to see if other genes also play a role in transplant success. This is important because patients of African ancestry often have worse transplant outcomes and are underrepresented in genetic studies. By looking at more genetic details, we hope to better understand why some transplants succeed and others face challenges.

Why it matters

Potential benefit: If successful, this work could lead to better ways to predict kidney transplant outcomes and help doctors personalize care, particularly for patients of African ancestry.

How similar studies have gone: Previous work by this team has shown that combining different genetic risk factors, including APOL1, can improve predictions for kidney disease.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Kiryluk, Krzysztof — Columbia University Health Sciences
  • Study coordinator: Kiryluk, Krzysztof

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.